相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells
Ali Razaghi et al.
EXPERIMENTAL CELL RESEARCH (2017)
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor
Tiziana Vaisitti et al.
HAEMATOLOGICA (2017)
Relevance of necroptosis in cancer
Najoua Lalaoui et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Suman Chatterjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
Evangelos Giampazolias et al.
NATURE CELL BIOLOGY (2017)
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Akane Inoue-Yamauchi et al.
NATURE COMMUNICATIONS (2017)
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor
Tiziana Vaisitti et al.
HAEMATOLOGICA (2017)
CIMAvax-EGF: A New Therapeutic vaccine for Advanced Non-Small Cell Lung Cancer Patients
Danay Saavedra et al.
FRONTIERS IN IMMUNOLOGY (2017)
EGFR Family Members' Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer
Elizabeth Henson et al.
CANCERS (2017)
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death
Elodie Lafont et al.
EMBO JOURNAL (2017)
Using circulating cell-free DNA to monitor personalized cancer therapy
Michael Oellerich et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells
Chi-Hung R. Or et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
George Mihai Nitulescu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer
Shiven B. Patel et al.
ONCOTARGETS AND THERAPY (2016)
Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection
Le Chang et al.
ANALYTICA CHIMICA ACTA (2016)
New role of E3 ubiquitin ligase in the regulation of necroptosis
Jinho Seo et al.
BMB REPORTS (2016)
Targeting cell death signalling in cancer: minimising 'Collateral damage'
Joanna L. Fox et al.
BRITISH JOURNAL OF CANCER (2016)
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
Robert A. Fenstermaker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked
Sabine Hannes et al.
CANCER LETTERS (2016)
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses
Yusuke Shono et al.
CANCER RESEARCH (2016)
Cancer therapy in the necroptosis era
Z. Su et al.
CELL DEATH AND DIFFERENTIATION (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
Pedro C. Rodriguez et al.
CLINICAL CANCER RESEARCH (2016)
Six1 induces protein synthesis signaling expression in duck myoblasts mainly via up-regulation of mTOR
Haohan Wang et al.
GENETICS AND MOLECULAR BIOLOGY (2016)
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Erika Larrea et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Review of the recombinant human interferon gamma as an immunotherapeutic: Impacts of production platforms and glycosylation
Ali Razaghi et al.
JOURNAL OF BIOTECHNOLOGY (2016)
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Elizabeth A. Punnoose et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
Michelle A. Hughes et al.
MOLECULAR CELL (2016)
CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3
Jinho Seo et al.
NATURE CELL BIOLOGY (2016)
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
S. Ma et al.
CELL DEATH & DISEASE (2016)
Discovery and clinical introduction of first-in-class imipridone ONC201
Joshua E. Allen et al.
ONCOTARGET (2016)
Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer
Sasagu Kurozumi et al.
CANCER MEDICINE (2016)
Mitochondrial survivin - an Achilles' heel in cancer chemoresistance
Michael J. Ausserlechner et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
VENETOCLAX: BCL-2 INHIBITION FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
G. Del Poeta et al.
DRUGS OF TODAY (2016)
The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line
Marzieh Armat et al.
Bosnian Journal of Basic Medical Sciences (2015)
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
Silvia von Karstedt et al.
CANCER CELL (2015)
Increased expression of Six1 correlates with progression and prognosis of prostate cancer
Jun Zeng et al.
CANCER CELL INTERNATIONAL (2015)
Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains
S. Iyer et al.
CELL DEATH AND DIFFERENTIATION (2015)
Cancer stem cells: a potential target for cancer therapy
Hong Qiu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues
E. Guerriero et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2015)
The SIX1-EYA transcriptional complex as a therapeutic target in cancer
Melanie A. Blevins et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
Petra Popovics et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Survivin: A molecular biomarker in cancer
Praveen Kumar Jaiswal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
Shundong Cang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata et al.
CANCER DISCOVERY (2015)
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
Collin M. Blakely et al.
CELL REPORTS (2015)
Role of AMP-Activated Protein Kinase in Cancer Therapy
Gauhar Rehman et al.
ARCHIV DER PHARMAZIE (2014)
Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma
Rong Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
IFN-γ down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
Mariko Oba et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
Giulia Grazia et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
Jing Zeng et al.
PLOS ONE (2014)
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Jiri Polivka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Molecularly targeted cancer therapy: some lessons from the past decade
Min Huang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Role of cetuximab in first-line treatment of metastatic colorectal cancer
Miguel Jhonatan Sotelo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan et al.
CANCER DISCOVERY (2014)
Current and Emerging Biomarkers of Cell Death in Human Disease
Kongning Li et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Companion diagnostics for targeted cancer drugs - clinical and regulatory aspects
Dana Olsen et al.
FRONTIERS IN ONCOLOGY (2014)
Review of EGFR TKls in etastatic NSCLC, including ongoing trials
Barbara Melosky
FRONTIERS IN ONCOLOGY (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
Maureen L. Drakes et al.
IMMUNOTARGETS AND THERAPY (2014)
Expedient Synthesis of Highly Potent Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Unique Selectivity for ML-IAP
Mitchell Vamos et al.
ACS CHEMICAL BIOLOGY (2013)
Application and interpretation of current autophagy inhibitors and activators
Ya-ping Yang et al.
ACTA PHARMACOLOGICA SINICA (2013)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
BH3 profiling - Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
Victoria Del Gaizo Moore et al.
CANCER LETTERS (2013)
Targeting apoptosis pathways in cancer stem cells
Michele Signore et al.
CANCER LETTERS (2013)
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
Yongjie Wei et al.
CELL (2013)
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Brandon Faubert et al.
CELL METABOLISM (2013)
Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer-Results from Phase I Clinical Trials
Toshiaki Tanaka et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Targeting the SIX1/EYA transcriptional complex as a potential anti-cancer therapy
Aaron Patrick et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinoma
Zhe Long Liang et al.
ONCOLOGY LETTERS (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma
Yasuhiro Oki et al.
BLOOD (2012)
The roles of FADD in extrinsic apoptosis and necroptosis
Eun-Woo Lee et al.
BMB REPORTS (2012)
Antibody-Based Immunotherapy of Cancer
Louis M. Weiner et al.
CELL (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
The role of TRADD in death receptor signaling
Yelena L. Pobezinskaya et al.
CELL CYCLE (2012)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma
Claire Fabre et al.
CLINICAL CANCER RESEARCH (2012)
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS
M. D. Vincent et al.
CURRENT ONCOLOGY (2012)
FADD Expression as a Prognosticator in Early-Stage Glottic Squamous Cell Carcinoma of the Larynx Treated Primarily With Radiotherapy
Michiel L. Schrijvers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
IgG-detection devices for the Tus-Ter-lock immuno-PCR diagnostic platform
Isabelle Morin et al.
ANALYST (2011)
Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?
Ashraf A. Khalil et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
K. Page et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma
Yutao Zhang et al.
DIAGNOSTIC PATHOLOGY (2011)
First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
A Novel Kinase Inhibitor of FADD Phosphorylation Chemosensitizes through the Inhibition of NF-κB
Katrina A. Schinske et al.
MOLECULAR CANCER THERAPEUTICS (2011)
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues
Guillaume Lambert et al.
NATURE REVIEWS CANCER (2011)
Nano-Bio-Chip Sensor Platform for Examination of Oral Exfoliative Cytology
Shannon E. Weigum et al.
CANCER PREVENTION RESEARCH (2010)
Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner
B. L. Probst et al.
CELL DEATH AND DIFFERENTIATION (2010)
Negative regulation of autophagy
C. Liang
CELL DEATH AND DIFFERENTIATION (2010)
Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia
Irene M. Ghobrial et al.
CLINICAL CANCER RESEARCH (2010)
Trastuzumab A Review of its Use as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
Karly P. Garnock-Jones et al.
DRUGS (2010)
Akt inhibitors in clinical development for the treatment of cancer
Sumanta Kumar Pal et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Ultrasensitive detection of antibodies using a new Tus-Ter-lock immunoPCR system
Isabelle Morin et al.
MOLECULAR BIOSYSTEMS (2010)
Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis
Stephanie L. Osborn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Jason A. Wilken et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Site-specific covalent attachment of DNA to proteins using a photoactivatable Tus-Ter complex
B. Dahdah Dahdah et al.
CHEMICAL COMMUNICATIONS (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
BNIP3 (Bcl-219 kDa Interacting Protein) Acts as Transcriptional Repressor of Apoptosis-Inducing Factor Expression Preventing Cell Death in Human Malignant Gliomas
Teralee R. Burton et al.
JOURNAL OF NEUROSCIENCE (2009)
Everolimus
Michael B. Atkins et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
PHOSPHORYLATION OF FADD (Fas-ASSOCIATED DEATH DOMAIN PROTEIN) AT SERINE 194 IS INCREASED IN THE PREFRONTAL CORTEX OF OPIATE ABUSERS: RELATION TO MITOGEN ACTIVATED PROTEIN KINASE, PHOSPHOPROTEIN ENRICHED IN ASTROCYTES OF 15 kDa, AND Akt SIGNALING PATHWAYS INVOLVED IN NEUROPLASTICITY
A. Ramos-Miguel et al.
NEUROSCIENCE (2009)
Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues
Mizuki Yamamoto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence
David B. Seligson et al.
CLINICAL CANCER RESEARCH (2007)
Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells
Edward A. Hirschowitz et al.
LUNG CANCER (2007)
c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications
P. Korkolopoulou et al.
HISTOPATHOLOGY (2007)
EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells
Wei-Zhong Ying et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy
Tateki Yoshino et al.
CLINICAL CANCER RESEARCH (2006)
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
GM Callagy et al.
CLINICAL CANCER RESEARCH (2006)
Chemotherapeutic approaches for targeting cell death pathways
M. Stacey Ricci et al.
ONCOLOGIST (2006)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer
A Dutton et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer
K Krysan et al.
CANCER RESEARCH (2004)
Arsenic trioxide (Trisenox (R)) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation
D Douer et al.
ONCOLOGIST (2003)
Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification
H Sakamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
